197 related articles for article (PubMed ID: 30916764)
1. Predictors of Nephrolithiasis, Osteoporosis, and Mortality in Primary Hyperparathyroidism.
Reid LJ; Muthukrishnan B; Patel D; Seckl JR; Gibb FW
J Clin Endocrinol Metab; 2019 Sep; 104(9):3692-3700. PubMed ID: 30916764
[TBL] [Abstract][Full Text] [Related]
2. The impact of obesity on the presentation of primary hyperparathyroidism.
Tran H; Grange JS; Adams-Huet B; Nwariaku FE; Rabaglia JL; Woodruff SL; Holt SA; Maalouf NM
J Clin Endocrinol Metab; 2014 Jul; 99(7):2359-64. PubMed ID: 24684459
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
4. Hypomagnesuria is Associated With Nephrolithiasis in Patients With Asymptomatic Primary Hyperparathyroidism.
Saponaro F; Marcocci C; Apicella M; Mazoni L; Borsari S; Pardi E; Di Giulio M; Carlucci F; Scalese M; Bilezikian JP; Cetani F
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32369583
[TBL] [Abstract][Full Text] [Related]
5. Predictors of renal function in primary hyperparathyroidism.
Walker MD; Nickolas T; Kepley A; Lee JA; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2014 May; 99(5):1885-92. PubMed ID: 24527717
[TBL] [Abstract][Full Text] [Related]
6. Normocalcaemic primary hyperparathyroidism: is nephrolithiasis more common than osteoporosis?
Wu KCJ; Anpalahan M
Intern Med J; 2023 Jan; 53(1):112-118. PubMed ID: 34435736
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in the presentation, course and outcomes of primary hyperparathyroidism.
Dadon T; Tsvetov G; Levi S; Gorshtein A; Slutzky-Shraga I; Hirsch D
Maturitas; 2021 Mar; 145():12-17. PubMed ID: 33541557
[TBL] [Abstract][Full Text] [Related]
8. The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism.
Düğer H; Bostan H; Gül Ü; Uçan B; Hepşen S; Sakız D; Akhanlı P; Çakal E; Kızılgül M
J Endocrinol Invest; 2023 Sep; 46(9):1935-1940. PubMed ID: 36929458
[TBL] [Abstract][Full Text] [Related]
9. Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
Lee JH; Kim JH; Hong AR; Kim SW; Shin CS
Osteoporos Int; 2017 May; 28(5):1667-1674. PubMed ID: 28175978
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Renal Function and Calcifications in Primary Hyperparathyroidism: A Nested Case-Control Study.
Ejlsmark-Svensson H; Bislev LS; Rolighed L; Sikjaer T; Rejnmark L
J Clin Endocrinol Metab; 2018 Sep; 103(9):3574-3583. PubMed ID: 29955845
[TBL] [Abstract][Full Text] [Related]
11. Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
Cong X; Shen L; Gu X
Urolithiasis; 2018 Oct; 46(5):453-457. PubMed ID: 29350243
[TBL] [Abstract][Full Text] [Related]
12. NEPHROLITHIASIS IN PRIMARY HYPERPARATHYROIDISM: A COMPARISON BETWEEN SILENT AND SYMPTOMATIC PATIENTS.
Castellano E; Attanasio R; Latina A; Visconti GL; Cassibba S; Borretta G
Endocr Pract; 2017 Feb; 23(2):157-162. PubMed ID: 27819765
[TBL] [Abstract][Full Text] [Related]
13. Nephrolithiasis and renal calcifications in primary hyperparathyroidism.
Rejnmark L; Vestergaard P; Mosekilde L
J Clin Endocrinol Metab; 2011 Aug; 96(8):2377-85. PubMed ID: 21646371
[TBL] [Abstract][Full Text] [Related]
14. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology.
Cipriani C; Biamonte F; Costa AG; Zhang C; Biondi P; Diacinti D; Pepe J; Piemonte S; Scillitani A; Minisola S; Bilezikian JP
J Clin Endocrinol Metab; 2015 Apr; 100(4):1309-15. PubMed ID: 25646791
[TBL] [Abstract][Full Text] [Related]
16. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.
Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR
N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327
[TBL] [Abstract][Full Text] [Related]
17. Screening for asymptomatic nephrolithiasis in primary hyperparathyroidism patients is warranted.
Zabolotniuk T; Guo M; Kwon M; Watanabe A; Teichman JMH; Wiseman SM
Am J Surg; 2024 May; 231():91-95. PubMed ID: 38480062
[TBL] [Abstract][Full Text] [Related]
18. The impact of vitamin D deficiency on clinical, biochemical and metabolic parameters in primary hyperparathyroidism.
Şengül Ayçiçek G; Aydoğan Bİ; Şahin M; Emral R; Erdoğan MF; Güllü S; Başkal N; Çorapçıoğlu D
Endocrinol Diabetes Nutr (Engl Ed); 2023 Jan; 70(1):56-62. PubMed ID: 36764749
[TBL] [Abstract][Full Text] [Related]
19. Association between hypomagnesemia and severity of primary hyperparathyroidism: a retrospective study.
Na D; Tao G; Shu-Ying L; Qin-Yi W; Xiao-Li Q; Yong-Fang L; Yang-Na O; Zhi-Feng S; Yan-Yi Y
BMC Endocr Disord; 2021 Aug; 21(1):170. PubMed ID: 34416890
[TBL] [Abstract][Full Text] [Related]
20. Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism.
Walker MD; Cong E; Kepley A; Di Tullio MR; Rundek T; Homma S; Lee JA; Liu R; Young P; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2014 Feb; 99(2):671-80. PubMed ID: 24285686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
